Drug Profile
Research programme: antifungals - Micrologix Biotech
Alternative Names: Antifungals research programme: Micrologix Biotech; Polyene macrolide research programme - Micrologix Biotech; Research programme: polyene macrolides - Micrologix BiotechLatest Information Update: 17 Aug 2004
Price :
$50
*
At a glance
- Originator MIGENIX
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 17 Aug 2004 Discontinued - Preclinical for Mycoses in Canada (unspecified route)
- 17 Aug 2004 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 28 May 2002 Preclinical trials in Mycoses in Canada (unspecified route)